Skip to main content
Annex II Entry 1588 CMR30/07/2020

Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine

Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.

Prohibited substance— Annex II, EU Regulation 1223/2009
Entry: 1588
CMR

Chemical identity and properties

PubChem 2D chemical structure for CAS 1593-77-7
CAS 1593-77-7PubChem CID 61899

Dodemorph

Dodemorph is a member of the class of morpholines that is 2,6-dimethylmorpholine in which the hydrogen attached to the nitrogen is replaced by a cyclododecyl group. It is a fungicide used for the control of powdery mildew, particularly in rose culture. It has a role as a sterol biosynthesis inhibitor and an antifungal agrochemical. It is a tertiary amino compound, a macrocycle and a morpholine fungicide. ChEBI

IUPAC name
4-cyclododecyl-2,6-dimethylmorpholine
Molecular formula
C18H35NO
Molecular weight
281.5 g/mol
Exact mass
281.271864740 Da
XLogP3
5.8
Topological polar surface area
12.5 Ų
Hydrogen-bond donors
0
Hydrogen-bond acceptors
2
Covalent units
1
Defined stereocentres
0

Also known as

MeltatoxDoazineDodemorpheDodemorph [BSI:ISO]Morpholine, 4-cyclododecyl-2,6-dimethyl-Dodemorphe [ISO-French]Cyclododecane, morpholine deriv.EINECS 216-474-9
16 more reported names
UNII-22O8GR86F0CHEBI:8196022O8GR86F0Dodemorphe (ISO-French)Dodemorph [ISO]DODEMORPH [MI]RefChem:1355444-Cyclododecyl-2,6-dimethylmorpholine (8CI)4-Cyclododecyl-2,6-dimethylmorpholine (8CI)(9CI)Cyclododecane, morpholine deriv. (9CI)216-474-9JMXKCYUTURMERF-UHFFFAOYSA-NDoazine; Dodemorph; MeltatoxDodemorph II4-Cyclododecyl-2,6-dimethylmorpholine #Dodemorph, PESTANAL(R), analytical standard
External database identifiers

Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Record details

Chemical name

Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine

Chemical / IUPAC name

Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine

Regulatory information

Regulation

(EU) 2019/831

See every entry this act set

CMR

CategoryCarcinogenicMutagenicReprotoxic
Cat. 2

Key data

Annex
Entry number
1588

Direct matches are limited for this record, so nearby entries from Annex II are shown as well.

Annex II 1589
Nearby record in the same annex

Imidazole

CAS: 288-32-4
EC: 206-019-2

What Annex II means for Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine

Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.

Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.

The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.

Compliance checklist

  • Verify this substance is absent from all raw materials and finished formulations.
  • Request absence confirmation or CoA from raw material suppliers.
  • Document the screening result in the Product Information File (PIF).
  • This substance has CMR classification. Review the CMR table above and verify current Annex II/III status before use.

Frequently asked questions

Yes. Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine is listed in Annex II of EU Cosmetics Regulation 1223/2009 and is prohibited as an intentionally added cosmetic ingredient. Article 17 provides a narrow exception for unintended small quantities that are technically unavoidable under good manufacturing practice, provided the product remains safe under Article 3.

CAS 1593-77-7 is the unique numerical identifier assigned to Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine by the Chemical Abstracts Service. In cosmetic compliance work, the CAS number is used to cross-reference the substance across regulatory databases, raw material specifications and safety assessment reports. Multiple EU annex entries may share the same CAS number if the same substance appears under different conditions or in different annexes.

Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine has a CMR (carcinogenic, mutagenic or reprotoxic) classification under EU CLP Regulation. Under Article 15 of EU Cosmetics Regulation 1223/2009, CMR substances of category 1A or 1B are prohibited in cosmetics unless specifically permitted. Category 2 CMR substances may be used only if assessed safe by the SCCS. Always verify current annex status and any applicable derogations before use.

Use the INCI Checker tool on this site to paste your full ingredient list (INCI) and scan it against all Annex II–VI entries. The tool highlights any ingredients that match restricted, prohibited or allergen-flagged records. This is useful for rapid compliance screening of finished product formulas or raw material declarations.

Source note for Annex II record Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine

This page summarizes one Annex II record for Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.

Use this record page to review Annex II conditions for Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine, but confirm any final regulatory decision against the current official annex wording and source files.

Tools & next steps

Check your formula

Paste a full INCI list to detect Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine and other flagged EU annex records in one pass.

INCI Checker

Compare entries

Compare Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine side by side with another annex record to review differences in restrictions, concentrations and annex placement.

Compare

Browse the annex

See all records in Annex II and compare regulatory conditions across substances in this annex.

Open Annex II